Sunday, September 20, 2020 2:40:28 PM
Reply...LMAO... To whom??
Current MCs
GILD is @ $90B
GSK is @ $97B
I'll stick with a reasonable $2B to $4B ASAP. Maybe a little more with STELLAR early Phase 2 results. Does ANYONE think that waiting thru Phase 3 Trials in smart? "Strike while the Iron is Hot". IMHFO.
My Good Wishes to all Medical personnel and unlimited Gratitude for their Efforts and the Risks taken to help as they work to help Every COVID patient. They have All earned Veteran Status, IMO. All Gave Some and Some Gave All...
Drug has some Logistics and administration to patient issues BUT is Much more effective than current treatments so far.
World wide distribution? The company is small and has limited resources and few skilled personal to accomplish a build out. GEM probably has the cheapest shares and 1.6B of them. They're going to WAIT?, NOT. They have the Votes? , YES. IMHFO.
There is competition attacking the Cy storm, one at a much smaller price to patients and in comparable Trials with easy logistics and easy patient administration of their drug. One is also another Repurposed drug moving quickly thru Trials with a proven Safety record.
Other competitive drugs have been FULLY discussed/debated here for some reason.
I HOPE the BOD has some Clearer reality in their decision making as some posters comments here are highly questionable. IMHFO...
Good Luck to Us All Here in supporting a Viable medical addition to Mankind in the Fight of this COVID Virus and the resulting Lung health issues.
FEATURED Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • Jun 14, 2024 2:07 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM